TMPRSS2-ERG confers resistance of prostate cancer to antiandrogens. - Sekar A; Selvadurai BR; Chatterjee R; Pal L; Verma A; Belugali Nataraj N; Drago Garcia D; Giri S; Genna A; Karatekin F; Gupta N; Ramesh-Kumar D; et al. (EMBO molecular medicine, 2026)